FM

Frazier Management Portfolio holdings

AUM $1.12M
This Quarter Return
-22.8%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
AUM
$320M
AUM Growth
+$320M
Cap. Flow
+$31.5M
Cap. Flow %
9.86%
Top 10 Hldgs %
86.11%
Holding
19
New
1
Increased
1
Reduced
2
Closed

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ANAB icon
1
AnaptysBio
ANAB
$569M
$81.1M 25.34% 2,316,447
MIRM icon
2
Mirum Pharmaceuticals
MIRM
$3.71B
$35.9M 11.22% +3,566,912 New +$35.9M
IOVA icon
3
Iovance Biotherapeutics
IOVA
$807M
$31.9M 9.96% 1,750,665 -437,666 -20% -$7.97M
KRYS icon
4
Krystal Biotech
KRYS
$4.27B
$31.1M 9.72% 895,000
COLL icon
5
Collegium Pharmaceutical
COLL
$1.22B
$21.7M 6.77% 1,887,332
TBIO
6
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$21.6M 6.76% 2,182,789 +500,000 +30% +$4.95M
GRTS
7
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$17.8M 5.57% 2,061,758
ALNA
8
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
$13.1M 4.1% 3,330,373
APTX
9
DELISTED
Aptinyx Inc. Common Stock
APTX
$11.1M 3.48% 3,190,079
ALPN
10
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$10.2M 3.18% 2,571,450
TPST icon
11
Tempest Therapeutics
TPST
$44M
$9.93M 3.1% 1,396,615
ITRM icon
12
Iterum Therapeutics
ITRM
$30.2M
$8.88M 2.78% 1,538,316
NBRV
13
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$8.51M 2.66% 4,256,526
ETTX
14
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$8.05M 2.52% 1,349,953
SRRA
15
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$3.17M 0.99% 8,112,121
CDTX icon
16
Cidara Therapeutics
CDTX
$1.66B
$2.62M 0.82% 1,312,258
KZR icon
17
Kezar Life Sciences
KZR
$28.9M
$1.53M 0.48% 467,743
BLCM
18
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$1.1M 0.35% 1,051,441
SYBX icon
19
Synlogic
SYBX
$17M
$647K 0.2% 282,649 -582,758 -67% -$1.33M